Blood test for Alzheimer's biomarkers may speed treatment start
An available blood test was found to identify Alzheimer's patients with and without tau and/or amyloid-beta clumps, needed for treatment.| Alzheimer's News Today
An available blood test was found to identify Alzheimer's patients with and without tau and/or amyloid-beta clumps, needed for treatment.| Alzheimer's News Today
Two proteins, neurofilament light chain and phosphorylated tau, can serve as markers of Huntington's disease progression, a study found.| Huntington's Disease News
